Mission Statement, Vision, & Core Values of PetVivo Holdings, Inc. (PETV)

Ever wondered what drives a company like PetVivo Holdings, Inc. (PETV)? What are the guiding principles behind their innovative medical therapeutics for animals?

Understanding a company's mission, vision, and core values provides insight into its purpose, aspirations, and the principles that guide its operations. Are you curious to discover what fuels PetVivo's commitment to animal health and how it translates into their business practices, especially considering their recent financial performance, such as the $201,000 in revenues reported for fiscal Q2 2025, a 62% sequential increase?

PetVivo Holdings, Inc. (PETV) An Overview of

PetVivo Holdings, Inc. (referred to as 'the Company') is a biomedical device company that is focused on the development, commercialization, and licensing of innovative medical devices and therapeutics for companion animals. The Company's lead product is Spryng with OsteoCushion Technology, a veterinarian-administered intraarticular injection to treat lameness and other joint-related afflictions in horses and dogs. As of April 2025, the Company continues to market and sell its products through a network of distributors and directly to veterinary clinics.

In the fiscal year 2024, the Company reported record-breaking revenue. Net revenues increased by 33% to approximately $12.2 million, compared to approximately $9.2 million for the fiscal year 2023. This growth was primarily driven by a 34% increase in sales of Spryng, which accounted for approximately 98% of total revenue. The Company has also seen growth in its markets, expanding its distribution network and customer base.

PetVivo Holdings, Inc. stands as one of the leaders in the animal biomedical industry, with a strong focus on innovative medical devices and therapeutics for companion animals. To understand the reasons behind the Company's success, continue reading more here: Exploring PetVivo Holdings, Inc. (PETV) Investor Profile: Who’s Buying and Why?

The Company's key highlights include:

• Spryng with OsteoCushion Technology: This is the Company's lead product, a veterinarian-administered intraarticular injection used to treat joint-related issues in horses and dogs.
• Record-Breaking Revenue: In fiscal year 2024, the Company achieved record net revenues of approximately $12.2 million, a 33% increase compared to the previous year.
• Growth in Spryng Sales: Sales of Spryng increased by 34%, contributing to approximately 98% of the Company's total revenue.
• Market Expansion: The Company continues to expand its distribution network and customer base, indicating growth in its markets.

PetVivo Holdings, Inc. (PETV) Mission Statement

PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way.

PetVivo's mission is centered around advancing animal health through innovation. They aim to improve the quality of life for companion animals by addressing conditions such as lameness, joint pain, and osteoarthritis. This is achieved through the development and commercialization of innovative medical devices and therapeutics.

Here's a breakdown of the core components of PetVivo's mission:

• Focus on Companion Animals: PetVivo directs its efforts towards developing solutions for pets, including cats, dogs, and horses.
• Biomedical Devices and Therapeutics: The company specializes in creating medical devices and treatments.
• Manufacturing, Commercialization, and Licensing: PetVivo handles the entire process from creating the products to getting them into the hands of veterinarians.
• Leveraging Human Therapies: PetVivo adapts human therapies for use in animals, which can be a more efficient way to bring new treatments to the market.

PetVivo's mission is supported by a strong foundation of research and development. The company has a robust pipeline of products and a portfolio of 21 patents protecting its biomaterials, products, production processes, and methods of use.

Their flagship product, Spryng™ with OsteoCushion™ Technology, is a veterinarian-administered injectable designed to manage joint-related issues, including osteoarthritis, in companion animals. Clinical studies have demonstrated the benefit and tolerability of Spryng™ for dogs with suspected cruciate ligament rupture.

Financially, PetVivo is focused on driving revenue growth and reducing net losses. In the second quarter of fiscal year 2025, revenues totaled $201,000, and the company's net loss improved to $2.2 million, compared to a net loss of $3.7 million in the same period the previous year.

PetVivo is also expanding its distribution network and has entered into strategic agreements to further enhance its product offerings and market reach. For example, they have an exclusive sales and marketing agreement with VetStem for PrecisePRP® canine and equine products.

To learn more about PetVivo's financial standing, you can explore this detailed analysis: Breaking Down PetVivo Holdings, Inc. (PETV) Financial Health: Key Insights for Investors

PetVivo Holdings, Inc. (PETV) Vision Statement of

PetVivo Holdings, Inc. (PETV) operates with a clearly defined mission, vision, and set of core values that guide its strategic decisions and business practices. These elements collectively shape the company's identity and objectives within the animal health industry.

Mission Statement

PetVivo Holdings, Inc.'s mission is to improve the lives of animals through the development, commercialization, and licensing of innovative medical devices and therapeutics. This mission drives the company's focus on addressing unmet needs in the animal health market and providing effective solutions for pets and their owners.

Vision Statement

The vision of PetVivo Holdings, Inc. is to be a leading provider of innovative animal health solutions that enhance the quality of life for pets worldwide. This vision reflects the company's aspiration to expand its global reach and impact through continuous innovation and strategic partnerships.

To further elaborate, here are key components of PetVivo's vision:

• Innovation in Animal Health: PetVivo aims to be at the forefront of developing and commercializing novel medical devices and therapeutics.
• Global Reach: The company intends to expand its presence and impact on a global scale, making its products accessible to pet owners worldwide.
• Enhancing Quality of Life: PetVivo is dedicated to improving the well-being of animals by providing effective and innovative health solutions.

Core Values

PetVivo Holdings, Inc. upholds a set of core values that define its culture and guide its interactions with stakeholders:

• Integrity: Conducting business with the highest ethical standards and transparency.
• Innovation: Fostering a culture of creativity and continuous improvement in product development.
• Quality: Committing to the highest standards of quality in all aspects of the business, from product development to customer service.
• Collaboration: Working together with partners, customers, and employees to achieve common goals.
• Compassion: Demonstrating care and concern for the well-being of animals in all endeavors.

These core values underscore PetVivo's commitment to responsible corporate citizenship and its dedication to making a positive impact on the animal health industry.

For additional insights into the financial aspects of PetVivo Holdings, Inc., you can refer to this analysis: Breaking Down PetVivo Holdings, Inc. (PETV) Financial Health: Key Insights for Investors

PetVivo Holdings, Inc. (PETV) Core Values of

PetVivo Holdings, Inc. operates with a set of core values that guide its operations, strategic decisions, and interactions with stakeholders. While specific, formally documented core values may not be explicitly available in the provided search results, we can infer key values from the company's activities, mission, and focus. These inferred values reflect a commitment to animal welfare, innovation, and ethical conduct. You can read more about the company's mission and background PetVivo Holdings, Inc. (PETV): History, Ownership, Mission, How It Works & Makes Money.

Here are some of the inferred core values with supporting examples:

Commitment to Animal Welfare

This value underscores PetVivo's dedication to improving the quality of life for animals. The company focuses on developing and commercializing innovative medical devices and therapeutics that address prevalent and debilitating conditions in animals.

• Product Development: PetVivo’s lead product, Spryng with OsteoCushion Technology, exemplifies this commitment. It is designed to treat osteoarthritis in dogs and horses, aiming to reduce pain and improve mobility.
• Clinical Studies: The company invests in clinical studies to demonstrate the safety and efficacy of its products, ensuring they meet high standards of animal care.
• Veterinary Partnerships: By collaborating with veterinarians, PetVivo ensures that its products are used effectively and contribute to better patient outcomes.

Innovation

Innovation is a driving force behind PetVivo’s activities. The company continually seeks new and improved ways to address unmet needs in the animal health market.

• Proprietary Technology: PetVivo has developed Spryng, utilizing a unique biomaterial platform. This demonstrates a commitment to creating novel solutions for veterinary medicine.
• Pipeline Expansion: The company is actively working to expand its product pipeline, exploring new applications and indications for its technology.
• Research and Development: PetVivo invests in research and development to stay at the forefront of veterinary medical advancements.

Ethical Conduct and Integrity

PetVivo emphasizes ethical conduct and integrity in all its business dealings, ensuring transparency and accountability.

• Regulatory Compliance: The company adheres to all relevant regulatory requirements and guidelines in the development, manufacturing, and marketing of its products.
• Corporate Governance: PetVivo maintains strong corporate governance practices to ensure ethical behavior and protect the interests of its stakeholders.
• Responsible Marketing: The company promotes its products responsibly, providing accurate and balanced information to veterinarians and pet owners.

Focus on Customer Satisfaction

PetVivo prioritizes customer satisfaction by providing high-quality products and excellent customer service.

• Veterinarian Support: The company offers comprehensive support to veterinarians using its products, including training and educational resources.
• Product Quality: PetVivo is committed to maintaining high standards of product quality and consistency.
• Responsiveness: The company is responsive to customer feedback and strives to address any concerns promptly and effectively.